Sorsby Fundus Dystrophy (SFD) is a genetic eye disorder, meaning it is caused by changes, or mutations, in a person's DNA. Understanding the genetic basis of SFD is crucial for diagnosis, managing the condition, and making informed decisions about family planning.
SFD is caused by specific mutations in the TIMP3 (Tissue Inhibitor of Metalloproteinases 3) gene. This gene provides instructions for producing a protein that is essential for maintaining the extracellular matrix—a network of proteins and other molecules that provides structural support to cells in the retina. When the TIMP3 gene is mutated, it leads to the production of an abnormal protein that accumulates under the retina, disrupting its function and eventually leading to the degeneration of the macula and the growth of abnormal blood vessels.
The inheritance pattern of Sorsby Fundus Dystrophy is autosomal dominant. This means that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition. If a person has SFD, there is a 50% chance with each pregnancy that they will pass the mutated gene on to their child. Because it is a dominant condition, it often appears in multiple generations of a family, affecting both men and women equally.
Genetic testing plays a pivotal role in the management of SFD. A clinical diagnosis based on symptoms and eye exams can strongly suggest SFD, but genetic testing is required to confirm the diagnosis by identifying the specific mutation in the TIMP3 gene. Confirming the genetic cause is not only important for the individual patient but also for their family members, as it allows for predictive testing in relatives who may be at risk but have not yet developed symptoms.
For individuals with SFD who are considering starting a family, genetic counseling is highly recommended. A genetic counselor can provide detailed information about the risks of passing the condition to offspring and discuss available family planning options. These options may include preimplantation genetic testing (PGT), a procedure used in conjunction with in vitro fertilization (IVF) to screen embryos for the TIMP3 mutation before they are implanted, ensuring that the child will not inherit the condition.
Understanding the genetics of Sorsby Fundus Dystrophy empowers patients and their families to make informed healthcare decisions. Anyone with a family history of SFD or who has been diagnosed with the condition should consult their healthcare provider or a genetic counselor for personalized guidance.